DK
Dariyadevi Kantilal Hiran
About Dariyadevi Kantilal Hiran
Data last updated:
Dariyadevi Kantilal Hiran is a Director at Darnax Pharma Private Limited (since 2011), Director at Actgen Pharma Private Limited (since 2023) and Director at Sunflower Trading And Investment Pvt Ltd (since 1992). The companies operate in Pharma and Financial Services. The 3 current companies with reported revenue have a combined latest revenue of ₹45.70 Cr; the largest is Darnax Pharma Private Limited at ₹35.42 Cr (FY 2025). Earlier, Dariyadevi Kantilal Hiran was an Additional Director at Hiran Orgochem Limited (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Darnax Pharma Private Limited U24100MH2011PTC220735 | Director | 09 Aug 2011 | 2011 | ₹35.42 Cr (FY 2025) | Active |
 Actgen Pharma Private Limited U24239MH2008PTC179859 | Director | 06 Nov 2023 | 2008 | ₹10.17 Cr (FY 2023) | Active |
| Sunflower Trading And Investment Pvt Ltd U51900MH1989PTC053154 | Director | 21 Mar 1992 | 1989 | ₹11.8 Lakh (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hiran Orgochem Limited L51900MH1983PLC029596 | Additional Director | 31 Jan 2015 | 1983 | ₹1.30 Cr (FY 2015) | Under Liquidation |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dariyadevi Kantilal Hiran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naresh Kantilal Hiran | 02836556 | Darnax Pharma Private Limited | Additional Director |
| Rekha Naresh Hiran | 05182434 | Darnax Pharma Private Limited | Director |
| Kantilal Mangalchand Hiran | 00186885 | Actgen Pharma Private Limited , Sunflower Trading And Investment Pvt Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dariyadevi Kantilal Hiran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dariyadevi Kantilal Hiran
Dariyadevi Kantilal Hiran currently holds 3 directorships: Darnax Pharma Private Limited (Director, since 09 Aug 2011, revenue ₹35.42 Cr (FY 2025)); Actgen Pharma Private Limited (Director, since 06 Nov 2023, revenue ₹10.17 Cr (FY 2023)); Sunflower Trading And Investment Pvt Ltd (Director, since 21 Mar 1992, revenue ₹11.8 Lakh (FY 2022)).
Dariyadevi Kantilal Hiran was first appointed on 21 Mar 1992 as Director at Sunflower Trading And Investment Pvt Ltd. The most recent appointment on record is 06 Nov 2023 at Actgen Pharma Private Limited.
The 3 current companies of Dariyadevi Kantilal Hiran that report revenue have a combined latest revenue of ₹45.70 Cr: Darnax Pharma Private Limited ₹35.42 Cr (FY 2025); Actgen Pharma Private Limited ₹10.17 Cr (FY 2023); Sunflower Trading And Investment Pvt Ltd ₹11.8 Lakh (FY 2022).
Dariyadevi Kantilal Hiran held 1 earlier board appointment: Hiran Orgochem Limited (Additional Director, from 31 Jan 2015).
The current boards of Dariyadevi Kantilal Hiran's companies include Naresh Kantilal Hiran (Darnax Pharma Private Limited), Rekha Naresh Hiran (Darnax Pharma Private Limited), Kantilal Mangalchand Hiran (Actgen Pharma Private Limited).